Received Oct 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
long COVID; This spontaneous case was reported by a consumer and describes the occurrence of POST-ACUTE COVID-19 SYNDROME (long COVID) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The patient's past medical history included Asthma (childhood asthma exacerbated by the flu/High risk severe Asthma) and Flu (childhood asthma exacerbated by the flu). In 2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2025, the patient experienced POST-ACUTE COVID-19 SYNDROME (long COVID). At the time of the report, POST-ACUTE COVID-19 SYNDROME (long COVID) outcome was unknown. No concomitant medications were reported. The patient stated that she had nearly died from COVID this past month as she was 58 years old at high risk with asthma. The patient suffered from debilitating long COVID, which prevented her from working. The patient equated COVID to death row with an alligator and stated that it went through everything, her throat and her chest. She stated it had made a marked difference; she had been crawling on all fours, thought she was going to die from fatigue and experienced breathing issues, but now she was walking around, also stated that her throat felt a little bit better. The patient received mNEXSPIKE vaccine on 15-Oct-2025. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2025-790418 (E2B Linked Report). This case was linked to MOD-2025-790336 (Patient Link).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-790418:Daughter case
Medical History/Concurrent Conditions: Asthma (childhood asthma exacerbated by the flu/High risk severe Asthma); Flu (childhood asthma exacerbated by the flu)